Elsevier introduces geographical pricing pilot to support authors in low - and middle- income countries with equitable open access publishing options

The GPOA model, a publishing industry first, is set to take effect from January 2024. As part of the pilot, Elsevier will structure its article publishing charges for this subset of journals based on countries’ local economic conditions and average income. By tailoring pricing structures according to Gross National Income (GNI) per capita, a transparent and well-established measure used by many international organisations including Research4Life, Elsevier aims to reduce financial barriers that have traditionally hindered researchers and institutions from low and middle-income countries from publishing the latest research in Gold Open Access journals. Elsevier’s approach to GPOA and country banding based on GNI are outlined on our website. A full list of the journals taking part in this novel pilot can be found here. Elsevier will continue to waive APCs for authors in the lowest economic band and already provides affordable access to over 100,000 peer-reviewed resources for institutions in 120 low- and middle-income countries through Research4Life(新しいタブ／ウィンドウで開く).

Stuart Whayman, Managing Director, Researchers and Librarians, Elsevier, said: "We acknowledge that economic disparities between regions are one of the barriers to achieving a more inclusive world of research. With Geographical Pricing for Open Access, we aim to test and learn from a more globally equitable model that reflects local economic circumstances to help researchers in low and middle-income countries to publish open access and contribute to scientific advancement for the benefit of society. There is more to be done to achieve inclusive and equitable open access publishing, we hope this is one incremental step that supports this journey.”

Elsevier’s GPOA builds on the company’s longstanding commitment to advancing openness and inclusion in research. GPOA also builds on Elsevier’s commitment to pricing journal article publishing charges below the market average, relative to comparable quality. The introduction of this pilot programme marks a positive step towards achieving a fairer, more transparent, and globally equitable pricing structure for scholarly publishing. Elsevier will evaluate, continually, its impact and share our learnings with the communities we serve.

Increasing the representation of all global research communities is a key focus for Elsevier and in 2020, it launched its Inclusion & Diversity Advisory Board with distinguished experts to guide us on improving gender, race & ethnicity, and geographic representation across our own organisation and the wider academic community.

Read more about how Elsevier supports open access and knowledge sharing.

About Elsevier

As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, academic leaders, funders, R&D-intensive corporations, doctors, and nurses.

Elsevier employs 9,000 people worldwide, including over 2,500 technologists. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, medical education, and nursing education. Researchers and healthcare professionals rely on over 2,800 journals, including The Lancet(新しいタブ／ウィンドウで開く) and Cell(新しいタブ／ウィンドウで開く); 46,000+ eBook titles; and iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation(新しいタブ／ウィンドウで開く) and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. 

Elsevier is part of RELX(新しいタブ／ウィンドウで開く), a global provider of information-based analytics and decision tools for professional and business customers.